Alex Hammacher
Director/Board Member at BARINTHUS BIOTHERAPEUTICS PLC
Net worth: 7 287 $ as of 29/04/2024
Profile
Alex joined Oxford Science Enterprises as Head of Corporate Finance in October 2019.
He was previously a medical student at the University of Oxford and a junior doctor in Oxford before joining investment banking in 2007.
Over the course of 13 years, he worked on M&A and capital raising across healthcare, as well as energy and infrastructure.
He worked at UBS and then Lazard in Europe and the Australia Pacific region.
His experience includes both large pharma and medtech clients as well as early stage biotech and digital health, traditional and renewable energy generation and transmission for private and public market clients.
Alex co-ordinates all fundraising and exits across the enterprises, manages the Investment Committee process and reports on the Investment Portfolio.
He represents Oxford Science Enterprises on the boards of Vaccitech and Macrophox and is an observer on the board of Evox Therapeutics.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 09/05/2024 | 3,000 ( 0.01% ) | 7 287 $ | 29/04/2024 |
Alex Hammacher active positions
| Companies | Position | Start |
|---|---|---|
| BARINTHUS BIOTHERAPEUTICS PLC | Director/Board Member | 31/12/2019 |
Oxford Science Enterprises PLC
 Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom. | Director of Finance/CFO | 30/09/2019 |
Vaccitech (UK) Ltd.
 Vaccitech (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Vaccitech (UK) Ltd. researches in and develops seasonal flu vaccines. It engages in clinical programs for universal influenza and prostate cancer, MERS, and preclinical programs for other therapeutic infectious diseases indications. The company was founded by Adrian Hill and Sarah Gilbert and is headquartered in Oxford, the United Kingdom. | Director/Board Member | 30/12/2019 |
Former positions of Alex Hammacher
| Companies | Position | End |
|---|---|---|
Lazard Pty Ltd.
 Lazard Pty Ltd. Investment ManagersFinance Lazard Pty Ltd. provides financial advisory and asset management services. Its principal activities are focused on advisory, comprising mergers, acquisition, equity capital markets transactions and private equity services. The company was founded in 2004 and is headquartered in Sydney, Australia. | Director/Board Member | 30/09/2019 |
UBS Investment Bank AG
 UBS Investment Bank AG Investment ManagersFinance Part of UBS Group AG, UBS Investment Bank AG is a financial institution based in Geneva, Switzerland. The Swiss company offers a range of banking solutions for private clients, including accounts, mortgages, pension plans, and investment advice. The company also provides expert advice on financial matters for corporate clients and institutions. The company offers digital banking services, including e-banking and mobile banking, and allows customers to send money around the world in 131 currencies. UBS Investment Bank also provides investment views and financial market data. UBS Investment Bank recently acquired Credit Suisse Group AG and is approaching the task in a respectful and timely manner. | Director/Board Member | 31/08/2015 |
Training of Alex Hammacher
| University of Oxford | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BARINTHUS BIOTHERAPEUTICS PLC | Health Technology |
| Private companies | 4 |
|---|---|
Oxford Science Enterprises PLC
Oxford Science Enterprises PLC Investment ManagersFinance Oxford Science Enterprises PLC (Oxford Science Enterprises) is a venture capital firm founded in 2015. The firm is headquartered in Oxford, United Kingdom. | Finance |
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Vaccitech (UK) Ltd. researches in and develops seasonal flu vaccines. It engages in clinical programs for universal influenza and prostate cancer, MERS, and preclinical programs for other therapeutic infectious diseases indications. The company was founded by Adrian Hill and Sarah Gilbert and is headquartered in Oxford, the United Kingdom. | Commercial Services |
Lazard Pty Ltd.
Lazard Pty Ltd. Investment ManagersFinance Lazard Pty Ltd. provides financial advisory and asset management services. Its principal activities are focused on advisory, comprising mergers, acquisition, equity capital markets transactions and private equity services. The company was founded in 2004 and is headquartered in Sydney, Australia. | Finance |
UBS Investment Bank AG
UBS Investment Bank AG Investment ManagersFinance Part of UBS Group AG, UBS Investment Bank AG is a financial institution based in Geneva, Switzerland. The Swiss company offers a range of banking solutions for private clients, including accounts, mortgages, pension plans, and investment advice. The company also provides expert advice on financial matters for corporate clients and institutions. The company offers digital banking services, including e-banking and mobile banking, and allows customers to send money around the world in 131 currencies. UBS Investment Bank also provides investment views and financial market data. UBS Investment Bank recently acquired Credit Suisse Group AG and is approaching the task in a respectful and timely manner. | Finance |
- Stock Market
- Insiders
- Alex Hammacher
